Health Condition 1: C73- Malignant neoplasm of thyroid gland
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient undergoing USG guided FNAC of thyroid nodules at TMH. 2. Availability of USG images on PACS/reports on EMR. 3. Clinical and cytopathological data on EMR.
Exclusion criteria
Exclusion criteria: Exclusion criteria: 1. Incomplete medical records or non availability of USG reports. 2. Patients who have undergone USG guided FNAC outside TMC. 3. Patients who have been lost to follow up. 4. Patients who have undergone thyroid surgery in the past.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Assess efficacy of USG guided FNAC in obtaining diagnostic samples from thyroid nodules in terms of percentage of total FNACs performed taking Bethesda 1 as non-diagnostic/inadequate and Bethesda 2-6 as diagnostic/adequate. 2. To evaluate the accuracy of USG guided FNAC in predicting the final HPR in patients undergoing surgery in terms of True Positive, True Negative, False Positive and False Negative.Timepoint: 1. At the time of reporting of FNAC samples which is roughly one week from the date of sample collection. 2. After obtaining final histopathology report at the time of surgery. | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess performance of TIRADS classification on a prospectively maintained database, in risk stratification of thyroid nodules in terms of correlation of final HPR result in different TIRADS categories.Timepoint: After receiving final HPR (about 1 week after surgery), the baseline TIRADS score at the time of diagnostic workup would be correlated to the final HPR result. All cases would be followed up for surgical HPR at regular 1 week intervals. | — |
Countries
India
Contacts
ata Memorial Hospital, Mumbai